Both in Biotechnology
Acumen Pharmaceuticals vs Voyager Therapeutics
Over the past year ABOS returned +42.1% and VYGR returned −43.9%; their daily moves had a correlation of 0.35.
ABOS +42.1% VYGR −43.9%Growth of $1, one year, split-adjusted
| Metric | ABOS | VYGR |
|---|---|---|
| Price | $2.25 | $2.64 |
| Market cap | $162.4M | $162.7M |
| Today | −2.39% | −2.22% |
| 1 month | −23.1% | −25.4% |
| 6 months | +2.5% | −31.8% |
| Year to date | +6.4% | −32.8% |
| 1 year | +58.1% | −41.6% |
| Revenue growth (YoY) | — | −39.1% |
| Gross margin | — | 100.0% |
| Net margin | — | −773.2% |
| P/E (TTM) | — | — |
| Price / sales | — | 4.7× |
| Net cash | $78.6M | $116.3M |
| Dividend yield | — | — |
| Volatility (60d) | 72.1% | 46.0% |
| Short % of float | 7.5% | 7.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).